Butler University on Thursday announced Dr. Michael Hole, a Stanford University-educated physician and U.S. Air Force Reserve officer who grew up in rural Indiana, as its next executive vice president and provost.... Read More
Eli Lilly and Co. said Wednesday it plans to open a new Lilly Gateway Labs site in Philadelphia, part of a broader effort to help foster biotech startups and innovations.... Read More
Franciscan Health Indianapolis this week announced plans to build a new $60 million, 40-bed inpatient rehabilitation hospital on its south-side campus to accommodate patients recovering from strokes, cardiac events, brain injuries and other medical issues.... Read More
The clinical trial, announced last month, focuses on Beverly, Massachusetts-based Akston Bioscience Corp.’s Ambifect immune-enhancing therapy, with Purdue researchers looking to enroll about 10 dogs.... Read More
Fort Wayne-based hospital system Parkview Health on Tuesday announced it has formalized its previously interim managed-services agreement with financially struggling, Hamilton County-owned Riverview Health.... Read More
The company, which goes by Fanco, says its Closed-Fuel Cycle Nuclear Energy Park will be the first of its kind in the country, designed to reprocess and reuse spent nuclear fuel on-site.... Read More
A subsidiary of Fishers-based American Resources Corp. on Monday announced a $1.4 billion partnership with the U.S. Department of Defense and a North Carolina-based company to increase the domestic production of rare earth magnets.... Read More
Indianapolis-based Eli Lilly and Co. announced Monday that it plans to build a $3 billion manufacturing site in the Netherlands to produce oral medications, including its highly anticipated GLP-1 pill for weight loss, orforglipron.... Read More
The Indiana Utility Regulatory Commission on Wednesday approved a settlement between Duke Energy Indiana and large Indiana coal producers to possibly sell coal units that were expected to be replaced by natural gas units to a third party.... Read More
Indianapolis-based drug maker Eli Lilly and Co. on Wednesday announced it plans to spend more than $1.2 billion to expand and update its manufacturing site in Puerto Rico to increase production of oral medications, including its highly anticipated GLP-1 pill.... Read More
